Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An instance of aplastic anemia that is acquired during the lifetime of the individual.
Biomarker and diagnostic research for acquired aplastic anemia has been reported in the published literature.
5 clinical trials registered, 2 recruiting. Interventions under study include medical devices, drug therapy, other interventions, and procedural interventions. Pipeline includes 2 PHASE2, 1 PHASE1, 1 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT07259863](https://clinicaltrials.gov/study/NCT07259863) |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 8:09 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about acquired aplastic anemia
Clinico-Epidemiological Profile Of Acquired Aplastic Anemia Among Children At Assiut Governorate . |
— |
Assiut University |
NOT_YET_RECRUITING |
[NCT06646497](https://clinicaltrials.gov/study/NCT06646497) | Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years | PHASE2 | Assistance Publique - Hôpitaux de Paris | RECRUITING |
[NCT03047746](https://clinicaltrials.gov/study/NCT03047746) | Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF | NA | Children's Hospital of Philadelphia | ACTIVE_NOT_RECRUITING |
[NCT06752694](https://clinicaltrials.gov/study/NCT06752694) | Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia | PHASE2 | Fred Hutchinson Cancer Center | ACTIVE_NOT_RECRUITING |
[NCT06839456](https://clinicaltrials.gov/study/NCT06839456) | Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT | PHASE1 | Children's Hospital of Philadelphia | RECRUITING |
97 publications have been identified in PubMed for acquired aplastic anemia. Research spans Case Report / Case Series (27%), Clinical Trial Publication (19%), and Basic Science / Preclinical (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 26 | 27% |
Clinical study results | 18 | 19% |
Laboratory research | 14 | 14% |
Disease patterns and progression | 14 | 14% |
Research summaries | 13 | 13% |
Testing and diagnosis research | 9 | 9% |
New treatment approaches | 3 | 3% |
Wen X (2026). [PMID: 41617898](https://pubmed.ncbi.nlm.nih.gov/41617898/). *Annals of hematology*. [Case Report / Case Series]
Mohammed Saleh MF (2026). [PMID: 41488014](https://pubmed.ncbi.nlm.nih.gov/41488014/). *Therapeutic advances in hematology*. [Clinical Trial Publication]
Tan S (2026). [PMID: 41811900](https://pubmed.ncbi.nlm.nih.gov/41811900/). *Journal of immunology research*. [Case Report / Case Series]
Aleixo G (2026). [PMID: 41646329](https://pubmed.ncbi.nlm.nih.gov/41646329/). *Research square*. [Diagnostic / Biomarker]
Sato S (2026). [PMID: 41811578](https://pubmed.ncbi.nlm.nih.gov/41811578/). *International journal of hematology*. [Basic Science / Preclinical]
Bordbar M (2026). [PMID: 40702901](https://pubmed.ncbi.nlm.nih.gov/40702901/). *Haematologica*. [Clinical Trial Publication]
Pan L (2026). [PMID: 41659867](https://pubmed.ncbi.nlm.nih.gov/41659867/). *Frontiers in immunology*. [Diagnostic / Biomarker]
Fiallo PM (2026). [PMID: 41815621](https://pubmed.ncbi.nlm.nih.gov/41815621/). *Cureus*. [Case Report / Case Series]
Zhang Y (2026). [PMID: 41972887](https://pubmed.ncbi.nlm.nih.gov/41972887/). *Hematology*. [Epidemiology / Natural History]
Law AD (2026). [PMID: 41974584](https://pubmed.ncbi.nlm.nih.gov/41974584/). *Am J Hematol*. [Review / Meta-Analysis]